Date Filed | Type | Description |
08/01/2022 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
07/25/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
07/25/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
07/25/2022 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
07/21/2022 |
4
| SCHROEDER ALICE D. (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Disposed/sold 22,406 shares
@ $33.5, valued at
$750.6k
|
|
07/21/2022 |
4
| MOORE BRYANT M (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Disposed/sold 10,114 shares
@ $33.5, valued at
$338.8k
|
|
07/21/2022 |
4
| LEVINE JOSHUA (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Disposed/sold 37,387 shares
@ $33.5, valued at
$1.3M
|
|
07/21/2022 |
4
| Heine Lisa Wipperman (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Disposed/sold 26,287 shares
@ $33.5, valued at
$880.6k
|
|
07/21/2022 |
4
| Guerin Eric (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Disposed/sold 10,114 shares
@ $33.5, valued at
$338.8k
|
|
07/21/2022 |
4
| Daskal Ilan (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Disposed/sold 18,937 shares
@ $33.5, valued at
$634.4k
|
|
07/21/2022 |
4
| Sullivan Thomas Joseph (President and CEO) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Granted 648,554 shares
@ $0 Disposed/sold 720,903 shares
@ $33.5, valued at
$24.2M
|
|
07/21/2022 |
4
| Davies Benjamin Drew (Executive VP and CFO) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Granted 106,034 shares
@ $0 Disposed/sold 181,846 shares
@ $33.5, valued at
$6.1M
|
|
07/21/2022 |
4
| Noll Austin Francis III (Executive VP and CCO) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Granted 61,966 shares
@ $0 Disposed/sold 200,509 shares
@ $33.5, valued at
$6.7M
Disposed/sold 72,534 options to buy
@ $20.68, valued at
$1.5M
|
|
07/21/2022 |
4
| CHUNG DONG CHUNE CHRISTOPHER (Chief Medical Officer) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Granted 35,056 shares
@ $0 Disposed/sold 83,374 shares
@ $33.5, valued at
$2.8M
Disposed/sold 35,360 options to buy
@ $20.68, valued at
$731.2k
|
|
07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/21/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
07/21/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
07/21/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
07/21/2022 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
07/21/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
07/21/2022 |
8-K
| Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa... |
07/07/2022 |
8-K
| Quarterly results |
06/17/2022 |
4
| SCHROEDER ALICE D. (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Granted 5,075 shares
@ $0 |
|
06/17/2022 |
4
| MOORE BRYANT M (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Granted 4,315 shares
@ $0 |
|
06/17/2022 |
4
| LEVINE JOSHUA (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Granted 5,075 shares
@ $0 |
|
06/17/2022 |
4
| Heine Lisa Wipperman (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Granted 5,075 shares
@ $0 |
|
06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2022 |
4
| Daskal Ilan (Director) has filed a Form 4 on NATUS MEDICAL INC
Txns:
| Granted 5,075 shares
@ $0 |
|
06/15/2022 |
8-K
| Quarterly results |
06/02/2022 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
05/26/2022 |
SD
| Form SD - Specialized disclosure report: |
|